These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37695549)

  • 21. Prevalence and duration of gastrointestinal symptoms before diagnosis of Inflammatory Bowel Disease and predictors of timely specialist review: a population-based study.
    Blackwell J; Saxena S; Jayasooriya N; Bottle A; Petersen I; Hotopf M; Alexakis C; Pollok RC;
    J Crohns Colitis; 2020 Jul; ():. PubMed ID: 32667962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
    Simrén M; Axelsson J; Gillberg R; Abrahamsson H; Svedlund J; Björnsson ES
    Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.
    Teruel C; Garrido E; Mesonero F
    World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):78-90. PubMed ID: 26855814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
    Midenfjord I; Grinsvall C; Koj P; Carnerup I; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14156. PubMed ID: 33860970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Tomita T; Fukui H; Morishita D; Mori S; Oshima T; Shinzaki S; Miwa H
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.
    Barratt SM; Leeds JS; Robinson K; Lobo AJ; McAlindon ME; Sanders DS
    Dig Dis Sci; 2011 Nov; 56(11):3270-5. PubMed ID: 21695401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
    Halpin SJ; Ford AC
    Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
    Ozer M; Bengi G; Colak R; Cengiz O; Akpinar H
    Medicine (Baltimore); 2020 May; 99(19):e20067. PubMed ID: 32384473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission.
    Zargar A; Gooraji SA; Keshavarzi B; Haji Aghamohammadi AA
    Int J Prev Med; 2019; 10():10. PubMed ID: 30774844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The overlap between irritable bowel syndrome and organic gastrointestinal diseases.
    Aziz I; Simrén M
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):139-148. PubMed ID: 33189181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms in different diseases.
    Chen G; Wu X; Zhu H; Li K; Zhang J; Sun S; Wang H; Wang M; Shao B; Li H; Zhang Y; Du S
    J Gastroenterol; 2024 Nov; 59(11):1000-1010. PubMed ID: 39254836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Emotional and personality features of patients with irritable bowel syndrome and bowel inflammatory diseases].
    Mnatsakanyan MG; Dyukova GM; Pogromov AP; Tashchyan OV
    Klin Med (Mosk); 2016; 94(10):764-9. PubMed ID: 30299020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.
    Tomita T; Fukui H; Morishita D; Maeda A; Makizaki Y; Tanaka Y; Ohno H; Oshima T; Miwa H
    J Neurogastroenterol Motil; 2023 Jan; 29(1):102-112. PubMed ID: 36606441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irritable bowel syndrome in inflammatory bowel disease. Synergy in alterations of the gut-brain axis?
    Pérez de Arce E; Quera R; Beltrán CJ; Madrid AM; Nos P
    Gastroenterol Hepatol; 2022 Jan; 45(1):66-76. PubMed ID: 34023477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
    Quigley EM
    Therap Adv Gastroenterol; 2016 Mar; 9(2):199-212. PubMed ID: 26929782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.